MicroRNA binding site polymorphisms as biomarkers of cancer risk.
about
Cancer microRNAs: from subtype profiling to predictors of response to therapyPrinciples of microRNA involvement in human cancers.Association of co-stimulatory human B-lymphocyte antigen B7-2 (CD86) gene polymorphism with colorectal cancer riskCross-mapping events in miRNAs reveal potential miRNA-mimics and evolutionary implications.MicroRNA signatures differentiate melanoma subtypes.Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neckA Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate CancerMiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON ConsortiumSNP Regulation of microRNA Expression and Subsequent Colon Cancer RiskPrinciples for the post-GWAS functional characterization of cancer risk lociKey principles of miRNA involvement in human diseasesDifferentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.miRNAs and long noncoding RNAs as biomarkers in human diseases.Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signalingIn silico analysis of polymorphisms in microRNAs that target genes affecting aerobic glycolysis.MicroRNAs and Their Regulatory Role in Sugarcane.A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.A Single Nucleotide Polymorphism in HPGD Gene Is Associated with Prostate Cancer Risk.PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target Sites.Development of an AmpliSeq Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain
P2860
Q24594739-8CEA05D1-ADD7-43FE-BBF4-288F88C26B3BQ33579255-6D3831ED-DBEA-4402-AA2B-6410AEA8B03FQ33596591-D91FEC86-25AD-4B92-B1C9-93D6EBCEF1B2Q33921298-7A6F76EA-8081-424E-9325-4A3D408E06E0Q34182764-C487225D-DE38-49E6-9B18-45C134450E97Q34191041-0F6447E8-4747-427C-B3A5-26B5F5B9CFEBQ34359175-3D0A8368-7726-4DF3-BEEB-0E7CEBCF9AF2Q35327105-5377F497-4B24-4D6F-892B-30620ED73135Q35651285-8A92E2CC-806F-4184-89B0-B1AE8F20C9BCQ35859001-D11373F7-B2E9-4077-8835-CBD7AEF566F5Q35887461-9B3A1DF1-9B42-419D-A35B-C785B5F893D0Q35990222-74F67E6F-69B4-4BCE-82B5-4DD339A1F959Q37694781-556CE339-B074-4CB6-A4CE-3B5D2222DCE2Q38088011-6586E8D5-8B90-4DD0-A603-66CB9234DF0FQ38176533-2DFC7430-C57C-4936-B402-26AF7C2A770EQ38613298-8BE4339C-9194-4368-8A3E-63774F8431D4Q38800182-62DA36E6-1535-4BAC-BC8E-03BA4CCFE503Q39403544-F0A6E118-E8B1-401C-B8D2-D23FE4B97BB2Q40492655-0A42275E-94CD-492B-8151-8A3A6681AC21Q47098621-53EE2D47-6A67-4318-B82A-9D9D2039BA76Q55368142-548A5517-9E41-4F98-906F-76BEF6ADD2D8Q57072929-B96EBC20-D48F-47D7-85DD-4001C0E5441A
P2860
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
@en
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
@nl
type
label
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
@en
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
@nl
prefLabel
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
@en
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
@nl
P2860
P356
P1476
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
@en
P2093
Cory Pelletier
P2860
P304
P356
10.1586/ERM.10.59
P577
2010-09-01T00:00:00Z